NEOS Investment Management’s BridgeBio Pharma BBIO Stock Holding History

NEOS Investment Management’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-84,407	Closed	-$6.46M	–	588
2025 Q4	$6.46M	Sell	84,407 -12,154	-13%	-$798K	0.04%	293
2025 Q3	$5.02M	Sell	96,561 -27,026	-22%	-$1.32M	0.04%	301
2025 Q2	$5.34M	Sell	123,587 -25,530	-17%	-$929K	0.07%	235
2025 Q1	$5.15M	Buy	149,117 +7,145	+5%	+$241K	0.1%	193
2024 Q4	$3.9M	Buy	141,972 +29,896	+27%	+$773K	0.09%	201
2024 Q3	$2.85M	Buy	112,076 +24,787	+28%	+$651K	0.09%	212
2024 Q2	$2.21M	Buy	87,289 +36,371	+71%	+$994K	0.09%	202
2024 Q1	$1.57M	Buy	50,918 +32,617	+178%	+$1.11M	0.1%	195
2023 Q4	$739K	Buy	+18,301	New	+$550K	0.07%	221

Other funds holding BBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NEOS Investment Management's BBIO Position: Q1 2026 in Review

NEOS Investment Management sold out of BridgeBio Pharma (BBIO) in Q1 2026, closing a stake of 84,407 shares — an estimated $6.46M sold.

NEOS Investment Management first reported a position in BBIO in Q4 2023 and held it in 9 quarters. The position peaked at $6.46M in Q4 2025. 460 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

NEOS Investment Management reported no remaining BridgeBio Pharma position as of Q1 2026 after selling out during the quarter.
NEOS Investment Management sold 84,407 BridgeBio Pharma shares in Q1 2026, an estimated $6.46M.
NEOS Investment Management first reported a position in BridgeBio Pharma in Q4 2023 and held it in 9 quarters.
NEOS Investment Management's BridgeBio Pharma position peaked at $6.46M in Q4 2025.
460 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.